ROCHE FDA Approval NDA 017546

NDA 017546

ROCHE

FDA Drug Application

Application #017546

Application Sponsors

NDA 017546ROCHE

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION50MG/VIAL0NIPRIDESODIUM NITROPRUSSIDE

FDA Submissions

TYPE 1; Type 1 - New Molecular EntityORIG1AP1974-05-10PRIORITY
LABELING; LabelingSUPPL6AP1977-12-27
LABELING; LabelingSUPPL9AP1979-01-23
LABELING; LabelingSUPPL10AP1981-02-13
LABELING; LabelingSUPPL12AP1985-05-15
LABELING; LabelingSUPPL18AP1984-07-30
LABELING; LabelingSUPPL21AP1987-05-27
LABELING; LabelingSUPPL23AP1990-10-18

CDER Filings

ROCHE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 17546
            [companyName] => ROCHE
            [docInserts] => ["",""]
            [products] => [{"drugName":"NIPRIDE","activeIngredients":"SODIUM NITROPRUSSIDE","strength":"50MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NIPRIDE","submission":"SODIUM NITROPRUSSIDE","actionType":"50MG\/VIAL","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.